Why did ALT's other items show extreme volatility?

The stock price of ALT has experienced significant volatility on May 6, with a decrease of 7.37% from the previous day. The extreme volatility in ALT's stock price can be attributed to the following factors: 1. **Company's Financial Position**: Altimmune's cash reserves were reported at $131.9 million as of December 31, 2024. The company is expected to report top-line data from its Phase 2b IMPACT trial in MASH in Q2 2025, and has received FDA clearance for two additional indications for pemvidutide. The upcoming trial results and regulatory clearances could be causing investor anxiety and leading to volatile stock prices. 2. **Market Reaction to New Analyses**: Altimmune presented new analyses at the EASL International Liver Congress™ 2025, demonstrating the effectiveness of the MASH Resolution Index (MASHResInd) in predicting MASH resolution for patients treated with pemvidutide. The presentation of these findings could be influencing investor sentiment and leading to volatility in the stock price. In conclusion, the extreme volatility in ALT's stock price is likely a result of a combination of factors including the company's financial position and the market reaction to new analyses. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |ALT|ALT.O|Altimmune|20250507|6.5606|185|